
    
      Denufosol tetrasodium (INS37217) Intravitreal Injection may provide clinical benefit in
      treatment of uveitis associated macular edema (UME) by reducing retinal thickness as measured
      by OCT and possibly enabling recovery of vision loss associated with UME. Denufosol
      tetrasodium may also reverse the fluid accumulation of UME.
    
  